XML 60 R30.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation and Employee Benefit Plan (Tables)
9 Months Ended
Sep. 30, 2019
Compensation Related Costs [Abstract]  
Stock Option and RSU Activity
A summary of stock option activity under our stock plans during the nine months ended September 30, 2019 is as follows:
 
 
Outstanding Options
 
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Remaining
Contractual
Life (Years)
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(in thousands)
Balances at December 31, 2018
 
14,558,420

 
$
25.93

 
6.78
 
$
3,084

Added to plan
 

 
 
 
 
 
 
Granted
 
1,433,064

 
11.19

 
 
 
 
Exercised
 
(336,572
)
 
4.28

 
 
 
 
Cancelled
 
(687,050
)
 
24.82

 
 
 
 
Balances at September 30, 2019
 
14,967,862

 
25.06

 
6.28
 

Vested and expected to vest at September 30, 2019
 
14,632,346

 
25.23

 
6.22
 

Exercisable at September 30, 2019
 
9,238,860

 
28.75

 
4.77
 

RSU Activity and Related Information
A summary of our restricted stock units ("RSUs") activity and related information during the nine months ended September 30, 2019 is as follows:
 
 
Number of
Awards
Outstanding
 
Weighted
Average Grant
Date Fair
Value
 
 
 
 
 
Unvested Balance at December 31, 2018
 
16,784,800

 
$
18.74

Granted
 
3,052,644

 
12.20

Vested
 
(6,341,441
)
 
18.27

Forfeited
 
(839,062
)
 
17.58

Unvested Balance at September 30, 2019
 
12,656,941

 
17.48

Weighted-Average Valuation Assumptions
We used the following weighted-average assumptions in applying the Black-Scholes valuation model:
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
 
Risk-free interest rate
 
1.9% - 2.0%
 
2.8% - 2.8%
 
1.9% - 2.6%
 
2.5% - 2.8%
Expected term (years)
 
6.4 - 6.7
 
6.2 - 6.7
 
6.4 - 6.7
 
6.2 - 6.7
Expected dividend yield
 
 
 
 
Expected volatility
 
45.7%
 
56.1%
 
45.7% - 50.2%
 
54.6% - 56.1%
Employee and Non-Employee Stock-Based Compensation Expense
The following table summarizes the components of stock-based compensation expense in the consolidated statements of operations (in thousands):
 
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
 
 
2019
 
2018
 
2019
 
2018
 
 
 
 
 
 
 
 
 
Cost of revenue
 
$
6,793

 
$
16,156

 
$
31,557

 
$
20,025

Research and development
 
6,589

 
15,127

 
33,037

 
18,504

Sales and marketing
 
5,823

 
12,900

 
26,270

 
15,066

General and administrative
 
20,650

 
27,494

 
64,091

 
33,856

Total stock-based compensation
 
$
39,855

 
$
71,677

 
$
154,955

 
$
87,451